 pulmonari complic combin therapi cyclophosphamid prednison oral cyclophosphamid prednison standard treatment neoplasm system vascul frequenc idiopath interstiti lung diseas period case acut respiratori failur pneumocysti carinii pneumonia pcp patient oral cyclophosphamid prednison patient polyarter nodosa wegen granulomatosi bronchiol obliteran pneumonia chronic lymphocyt leukemia red blood cell aplasia hypoalbuminemia serum level g/dl daili therapi risk develop pcp none patient mm diagnosi neg human immunodefici viru patient oral cyclophosphamid prednison risk pcp high index suspicion aggress evalu opportunist infect patient consider trimethoprim-sulfamethoxazol prophylaxi develop quantit measur immunosuppress